Skip to main content

Table 1 Thymic epithelial tumors characteristics

From: Immune biomarkers in thymic epithelial tumors: expression patterns, prognostic value and comparison of diagnostic tests for PD-L1

 N = 103 patients
Histology WHO 2015
 Thymoma B2/B318 (17%)
 Thymoma B335 (34%)
 Thymoma B3/C4 (4%)
 Thymic carcinoma46 (45%)
Type
 Biopsy20 (19%)
 Surgical resection83 (81%)
Tumor
 Initial resection89 (86%)
 Recurrence4 (4%)
 Metastasis10 (10%)